Verily Life Sciences, formerly known as Google Life Sciences, and Johnson & Johnson jointly launched a new robotic surgery company called Verb Surgical.
The new company aims to develop a comprehensive surgical solutions platform using robotic capabilities and medical device technologies to improve patient outcomes, increase access to minimally invasive surgery and boost hospital efficiency.
"We believe Verb Surgical has the potential to change the future of surgery, not just robotic surgery," said Gary Pruden, chairman of Johnson & Johnson Medical Devices. "The team has already made meaningful progress on the robotics platform, which is being developed for application across a host of surgical specialties."
Scott Huennekens, who previously served as CEO of intravascular imaging company Volcano Corp., will serve as Verb Surgical's president and CEO.
"By maximizing the distinct capabilities of these two market-leading companies, we aim to develop novel technologies and solutions to help improve the standard of care around the world," Mr. Huennekens said. "Our name speaks for itself. We are a company dedicated to action and to making a difference in people's lives, in partnership with surgeons globally."
More articles on health IT:
58 EHR contracts, go-lives in 2015
3 of the biggest health IT rivalries: The cloud, EHRs & wearables
HCA's EHR shutdown over the weekend: 4 things to know